Brief: PaxMedica Grants Exclusive Pharmacy Distribution Rights For PAX-101 To Vox Nova, LLC
06/07/2023 14:36
July 6 (Reuters) - PaxMedica Inc PXMD.O :
* PAXMEDICA GRANTS EXCLUSIVE PHARMACY DISTRIBUTION RIGHTS
FOR
PAX-101 TO VOX NOVA, LLC
* PAXMEDICA INC - AGREEMENT FOR PAX-101 (SURAMIN IV)
DISTRIBUTION
IN U.S. FOR UP TO 7 YEARS
Source text for Eikon: ID:nGNX1RKCLs
Further company coverage: PXMD.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Kuvatris Therapeutics
See all newsBrief: PaxMedica Responds To Emergency Request For IV Suramin And Commits To Provide Immediate Access To PAX-101
PaxMedica rises on Malawi's request for access to sleeping sickness drug
Brief: Paxmedica Receives Emergency Request For Iv Suramin From African Health Ministry For Use In Treating Fatal Sleeping Sickness
Brief: PaxMedica Achieves Key Milestone In The Development Of PAX-101 And Provides Update On Potential NDA Submission
Brief: Paxmedica Announces Pricing Of $7.0 Million Public Offering